Clinical Trial Update: Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy, immunogenicity, and safety of liquid human rotavirus vaccine in healthy Chinese infants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Liquid Human Rotavirus Vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED | Results posted: 2013-06-24